NCT03888391View on ClinicalTrials.gov

12 Month Open Extension of TNS for ADHD.

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 1, 2014

Primary Completion Date

May 30, 2018

Study Completion Date

May 30, 2018

Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DEVICE

Active TNS

Trial Locations (1)

90095

UCLA Semel Institute, Los Angeles

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

James McGough

OTHER

NCT03888391 - 12 Month Open Extension of TNS for ADHD. | Biotech Hunter | Biotech Hunter